![Alison Moore](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alison Moore
Chief Executive Officer at
CODEXIS, INC.
Net worth: 693 902 $ as of 31/05/2026
Profile
Presently, Alison Moore occupies the position of Chief Technical Officer at Allogene Therapeutics, Inc. Dr. Moore is also on the board of Codexis, Inc. In the past Dr. Moore occupied the position of Senior Vice President-Process Development at Amgen, Inc. and Director-Chemistry, Manufacturing & Controls at Genentech, Inc. Alison Moore received a doctorate and an undergraduate degree from The University of Manchester.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CODEXIS, INC. 0.28% | 20/04/2026 | 250,506 ( 0.28% ) | 693 902 $ | 31/05/2026 |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Alison Moore active positions
| Companies | Position | Start |
|---|---|---|
| CODEXIS, INC. | Chief Executive Officer | 07/11/2025 |
| ARTIVA BIOTHERAPEUTICS, INC. | Director/Board Member | 21/10/2024 |
Former positions of Alison Moore
| Companies | Position | End |
|---|---|---|
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Director/Board Member | 01/10/2023 |
| ALLOGENE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 28/04/2023 |
| AMGEN INC. | Corporate Officer/Principal | 01/06/2018 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | General Counsel | 01/01/2006 |
Training of Alison Moore
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
67
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Codexis, Inc.
 Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Allogene Therapeutics, Inc.
 Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops natural killer cell-based therapies for patients suffering from autoimmune diseases and cancers | Health Technology |
- Stock Market
- Insiders
- Alison Moore
